Use of AI in Cardiometabolic Risk Prediction in Asian Indians
Use of Artificial Intelligence and Machine Learning in Cardiovascular Risk Prediction in Urban Asian Indians
1 other identifier
observational
500
1 country
1
Brief Summary
The Investigators are recruiting T2DM patients (n, 500) from Fortis-CDOC Hospital. Patients' weight, BMI, lipid profile, liver and kidney function tests, EGG, glycemic parameters, blood pressure, etc. will be entered in MS Excel sheets and appropriate data coding will be performed. Additional information on sleep hygiene, self-perceived stress, environmental pollution, and socio-economic status (education, occupation, and family annual income) will be collected by phone interviews. The entered data will be filtered for outliers and missing data will be excluded from the final data sheet. Johns Hopkins Team will perform the following:
- During the initial three months of the study, the plan is to obtain all requisite permissions for data gathering from the Institutional Ethics Review Committees of the respective institutions. The research assistant would be recruited from FORTIS-CDOC Hospital.
- Over the next 12 months, there will be data tabulation and gathering
- The last 3-4 months will be allocated to data analysis, application of AI algorithms (using training and testing datasets), and reporting of the data (meetings and manuscripts)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 3, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedJuly 12, 2023
July 1, 2023
1.1 years
July 3, 2023
July 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk of CVD Event
How many T2DM patients will get MI or Stroke within next five years.
5 years
Interventions
Retrospective and prospective analysis of patients data will be done.
Eligibility Criteria
Urban Indian Population with minimum duration of 5 years of T2DM.
You may qualify if:
- \- T2DM
You may not qualify if:
- T1DM
- Genetic Diabetes
- Gestational Diabetes
- Terminal Illness (Cancer)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Diabetes Foundation, Indialead
- National Diabetes Obesity and Cholesterol Foundationcollaborator
- Johns Hopkins Universitycollaborator
Study Sites (1)
Fortis Cdoc Hospital
New Delhi, National Capital Territory of Delhi, 110048, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
July 3, 2023
First Posted
July 11, 2023
Study Start
July 1, 2023
Primary Completion
July 31, 2024
Study Completion
August 30, 2024
Last Updated
July 12, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share